Off-Label Drift: How AI Pushes Drugs Beyond Their Approved Indications — And What Pharma Must Do About It
Nobody at Novo Nordisk promoted Ozempic for fatty liver disease. Nobody had to. Ask ChatGPT whether semaglutide helps with metabolic-associated […]











